Exagen (XGN) Other Operating Expenses (2018 - 2023)

Exagen (XGN) has reported Other Operating Expenses for 6 consecutive years, with -$17.5 million the latest figure, recorded in Q4 2023.

• Other Operating Expenses for Q4 2023 came in at -$17.5 million, down 247.88% year-over-year; the trailing twelve-month figure through Sep 2024 was -$17.5 million (down 159.66% YoY), and the FY2022 annual result was $29.7 million, up 44.36% from the prior year.
• Other Operating Expenses was -$17.5 million for Q4 2023 at Exagen, down from $5.7 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $11.8 million in Q4 2022 and troughed at -$17.5 million in Q4 2023.
• Average Other Operating Expenses over 5 years is $4.3 million, with a median of $5.0 million recorded in 2019.
• Year-over-year, Other Operating Expenses soared 139.22% in 2022 and sank 247.88% in 2023.
• Over 5 years, Other Operating Expenses stood at $4.6 million in 2019, then retreated by 5.58% to $4.3 million in 2020, then gained by 13.93% to $4.9 million in 2021, then surged by 139.22% to $11.8 million in 2022, then tumbled by 247.88% to -$17.5 million in 2023.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$17.5 million in Q4 2023, $5.7 million in Q3 2023, and $5.8 million in Q2 2023.